A more in-depth study conducted in the same year found that METTL3 was significantly more abundant in AML and promoted the mRNA translation of c-MYC (proto-oncogene), BCL2 (BCL2 apoptosis regulator), and phosphatase and tensin homolog (PTEN) (51). The gene discussed is BCL2; the disease is acute myeloid leukemia.